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Cross-linked enzyme aggregates (CLEAs) have emerged as interesting biocatalyst design for immobilization. These new generation
enzyme biocatalysts, CLEAs, in addition to exhibiting good mechanical stability, can be highly active, since they do not include
large amounts of foreign particulate nonenzymatic material and may have increased stability. Naringinase (NGase) is an enzyme
complex with high potential in pharmaceutical and food industries. In fact, NGase can be used in the biotransformation of
steroids, of antibiotics and mainly on glycosides hydrolysis. In this paper, the formation of CLEAs was tried using ammonium
sulphate, polyethylene glycol 6000 and tert-butyl alcohol as precipitant agents and glutaraldehyde as cross-linking agent, at
diﬀerent pH, time, and temperature conditions. However, among the precipitant agents tested, only tert-butyl alcohol cross-
linked with glutaraldehyde allowed the formation of CLEAs, at pH 4.0 and at temperature between 7 and 10
◦C. Diﬀerent enzyme
loadingswere tested.TheNGase-CLEAswerehighlyeﬀective in naringinhydrolysis.TheoperationalstabilityoftheNGase-CLEAs
aggregates was studied through six successive reutilizations.
1.Introduction
Cross-linked enzyme aggregates (CLEAs) have emerged as
interesting biocatalysts design for immobilization. Addition-
ally, since precipitation can be used on the puriﬁcation of
enzymes, and on the preparation of CLEAs, this technique
may integrate in a single/or reduced operation: enzyme
puriﬁcation and immobilization.
This new generation of biocatalysts, CLEAs, in addition
to exhibiting good mechanical stability, can be highly
active, since they do not include large amounts of foreign
particulate nonenzymatic material and may have increased
stability. The CLEAs technology present many advantages
on diﬀerent applications, as it is simple and amenable to
rapid optimization, leading to low costs and short time-
to-market processes. The self-immobilization techniques of
CLEAs are referred to as providing higher volumetric and
speciﬁc activity.
The cross-linking agents such as glutaraldehyde, ethylene
polymersandaldehydedextran,bindtotheenzymeswithout
the need for support when they are close [1–3].
Immobilization by cross-linked enzyme aggregates
(CLEAs) involves the precipitation mechanism of enzymes
by salting out, addition of nonionic polymers or mixture of
solvents. The most common used precipitating agents are
ammonium sulphate, polyethylene glycol (PEG 6000, PEG
8000), or ter-butyl alcohol among others [3, 4].
Therefore, the formation of CLEAS comprises two
distinct steps. The ﬁrst involves the physical aggregation of
the enzyme by nondenaturing methods, to further establish
the chemical bonds between the enzymes by cross-linked via
cross-linking agents [1, 3–5]. Precipitation, by the addition
of salts, organic solvents, or nonionic polymers to aqueous
solutions of proteins, is a commonly used method for
protein puriﬁcation [1]. The resulting physical aggregates
of enzyme molecules are supramolecular structures that are
held together by noncovalent bonding and can be easily
redissolved in water. The formation of CLEAs is based on the
reaction between glutaraldehyde or other cross-linking agent
and the NH2 groups located on the surface of the enzyme,
leading to formation of insoluble aggregates, stable and
catalytically active [2–6]. Due to the diﬀerent biochemical2 Enzyme Research
and structural properties of proteins the best precipitant and
cross-linker can vary from one enzyme to another.
The nature of the enzyme, the residues of serine and
lysine mainly present in the enzyme protein, the number
of protein subunits are among the many factors that
inﬂuence the formation of CLEAs [1, 5, 6]. In addition
to the properties of enzymes, the mode and duration of
the precipitation process, the concentration of cross-linking
agent, and the conditions of temperature and pH are other
factors with great importance [1, 5].
This method of immobilization can lead to changes in
enzyme activity due to the establishment of chemical bonds
that can alter the enzyme structure and lead to a loss or
increaseinactivity[1,5].Thesemodiﬁcationsmaybeusedto
model the selectivity of the enzyme for a particular substrate
or product formation, or lead to a change in the main
use of the enzyme [1, 2, 5]. In fact, it is not unusual to
have a modiﬁcation of enzyme activity and selectivity when
resorting to the formation of CLEAs, which may lead to
diﬀerentapplicantwithadditional beneﬁtinthestabilization
of enzymes, including their three-dimensional structure [1,
2, 4, 5].
Therefore,thetechnologyofCLEAsanalternativeimmo-
bilization procedure has several advantages in the industrial
context and appears as a simple, economical, and easy
optimization for the immobilization of enzymes, allowing
the selection and retention of enzymatic activity in aqueous
media and within a wide range of pH and temperature
[5, 7, 8].
Naringinase is an enzyme complex obtained from fungi
such as Penicillium decumbens, Aspergillus sp. Aspergillus
niger, Aspergillus oryzae, or Rhizopus nigricans.I ti sa
heterodimer of 168kDa composed of two subunits, the α-
L-ramnosidase and β-D-glucosidase [9, 10]. The hydrolysis
of naringin into prunin liberates one molecule of rhamnose
while the hydrolysis of prunin into naringenin liberates one
molecule of glucose.
The high cost of naringinase production has limited its
industrialapplication.Toovercomethisproblem,thecloning
andexpressionofthegeneforα-L-rhamnosidaseinE.coliare
very promising [11], increasing the potential applications in
pharmaceutical and food industries [9, 12–15]. Naringinase
can be used in the biotransformation of steroids, antibiotics,
and mainly on glycosides hydrolysis. Among ﬂavonoids,
naringin can be hydrolyzed by naringinase to naringenin
and to the reducing sugars ramnose and glucose. Naringin,
the substrate used in this bioconversion, and the product,
its aglycone, naringenin, are compounds with important
biological and pharmacological activities, such as anti-
oxidant, anti-inﬂammatory, or anticancer. Simultaneously,
naringinase enables sweeten fruit juices, as naringin has a
bitter taste and naringenin is tasteless, maintaining product
stability, organoleptic characteristics, and other inherent
properties of antioxidant compounds, leading to increased
business value [9, 10, 16].
The purpose of this work was the development and
optimization of biocatalysts using the immobilization in
cross-link aggregates (CLEAs). This work, using as model
system the hydrolysis of naringin to naringenin and reducing
sugars with naringinase encapsulated in CLEAs, aims to
provide a suitable approach on selecting a suitable set of
precipitant, cross-linking and polymerization agents, and
conditions to enzyme immobilization.
2.MaterialsandMethods
2.1. Enzyme and Chemicals. Naringinase (CAS no. 9068-31-
9, cat. No. 1385) from Penicillium decumbens was obtained
from Sigma-Aldrich and stored at −20◦C. The lyophilized
naringinase (NGase) was dissolved in the appropriate buﬀer
solution and kept at 4◦C until use. Naringin and naringenin
were obtained from Sigma-Aldrich, St. Louis, Mo, USA. All
other reagents used were of analytical grade and obtained
from diﬀerent sources.
2.2. Analytical Methods. The reducing sugars concentra-
tion was determined using the dinitrosalicylic acid (DNS)
microassay at λ = 545nm (BioPhotometer spectrophotome-
ter) [17].
The protein content was determined using Bradford
microassay, from Bio-Rad protein procedure, at λ = 595nm
(BioPhotometer spectrophotometer), using a naringinase
calibration curve [18].
2.3. Preparation of CLEAs. The formation of NGase-CLEAs
was tried using the precipitant agents, ammonium sulphate,
polyethylene glycol 6000 and alcohol tert-butyl and glu-
taraldehyde as cross-linking agent, at diﬀerent pH, time,
naringinase concentration, and temperature conditions.
Initially, the preparation of CLEAs was carried out in 24
microwell plates, adding 0.5mL of naringinase (0.5mg/mL)
to 0.5, 1.0, 1.5, and 2.0mL of ammonium sulphate 50%
(w/v) and sodium acetate buﬀer (pH = 4.0) to a ﬁnal volume
of 2.5mL. After 2, 6, 24, and 48h were added 0.5mL of
glutaraldehyde 25% (v/v) to each well of the microtiter plate.
PEG 6000 was another precipitant tested. This study
was carried out adding 2.0mL of naringinase solutions with
diﬀerent concentrations (0.5, 1.0, 1.5, and 2.0mg/mL), in
acetate buﬀer pH = 4.0, to PEG 6000 and stirred at 60rpm
for 1 hour. Then, to make the cross-linking occur, 0.5mL
of glutaraldehyde 25% (v/v) was added and kept stirring for
2h. CLEAs formation occurred during 48h. After that, they
were centrifuged at 5000rpm for 10min. The supernatant
wasremovedandtheCLEAsweresuspendedinacetatebuﬀer
20mM pH 4.0, centrifuged at 5000rpm for 10 minutes. This
stepwasrepeatedtwiceandtheCLEAsusedinbioconversion
trials.
The immobilization of naringinase was also performed
using tert-butyl alcohol as precipitant agent. 2mL of naring-
inase solutions with diﬀerent concentrations (0.5, 1.0, 1.5,
2.0, 4.0, 6.0, and 8.0mg/mL) in acetate buﬀer 20mM, pH =
4.0, was placed in each tube, added with 2.0mL of tert-butyl
alcohol and left at 60rpm for 1 hour.
The cross-linking reaction was performed by adding
0.3mL and 0.5mL of glutaraldehyde 25% (v/v) and pro-
ceeded, under shaking at 60rpm for 2h. The formation of
CLEAs was left to occur for 48h. Afterwards, they wereEnzyme Research 3
centrifuged at 5000rpm for 20min. The supernatant was
removedandNGase-CLEAsweresuspendedinacetatebuﬀer
solution. Centrifuged again at 5000rpm for 20 minutes, this
step was repeated twice.
The above mentioned procedure was repeated with
naringinase solutions of diﬀerent concentrations at pH 6.0
and pH 10.0.
2.4. Bioconversion Studies. The naringin hydrolysis was car-
ried out in standard solutions in acetate buﬀer (20.0mM),
at pH 4.0. The naringin concentration varied from 0.5 to
4.0mg/mL. A naringinase concentration of 500mg/L was
used in free and immobilized enzyme studies.
The CLEAs aggregate activities were evaluated following
the reducing sugars formation by DNS method and the
protein in reaction media was evaluated following Bradford’s
method.
After collecting samples, the reaction was immediately
stoppedbyloweringthetemperaturebelow0◦C.Theenzyme
activity was evaluated according to the initial rate method,
through determination of reducing sugars concentration of
the collected samples, using DNS assay. Each data point
of kinetic measurements was performed in an individual
experiment, in triplicate.
The ﬁt of the Michaelis-Menten model {v = ([S] ·
vmax)/([S] + kM)}{v—initial rate (mM min−1)), [S]—
substrate concentration (mM), vmax-maximum initial rate
(mM min−1), kM-Michaelis-Menten constant (mM)} to
experimental data was carried out through nonlinear regres-
sion by minimising the residual sum of squares between the
experimental data points of the initial rate versus substrate
concentration and those estimated by the model, using
Solver add-in from Microsoft Excel 2003 for Windows XP,
considering the following options: Newton method; 100
iterations, precision of 10−6, 5% of tolerance and 1 ×
10
−4 convergence. The nonlinear regression parameters were
constricted to positive numbers.
2.5. Stability Studies. To test the stability of the immobilized
naringinase, the NGase-CLEAs were reused six times on
the hydrolysis of naringin, in acetate buﬀer 20mM, pH 4.0
(Figure 2). After each run of 60 minutes, the biocatalyst were
separated and washed with acetate buﬀer 20mM, pH 4.0.
The reaction medium was then replaced by fresh medium
a n dan e wr u nt o o kp l a c e .
2.6. Eﬀect of Temperature and Substrate Concentration. The
eﬀect of substrate concentration and temperature on the
hydrolysisofnaringinbynaringinaseencapsulatedonCLEAs
was studied according to response surface methodology
(RSM) based on a central composite rotational design
(CCRD). The selection of the values of two variables under
study for the experimental design was developed, based on
the results of preliminary tests, using the computer program
“StatisticaTM” (version 6 from Statsoft, USA). This program
allowed the calculation of values for the sets of experimental
points of the CCRD design from the central point that
has been established. The ﬁve levels coded and decoded to
Table 1: Coded and decoded level for experimental variables,
naringin concentration, and temperature.
CCRD [Naringin] (mg/L) Temperature (◦C)
−
√
2 0.9 23.8
−1 1.5 30.0
0 3.0 45.0
+1 4.5 60.0
+
√
2 5.1 66.2
the point set of experimental variables, temperature, and
concentration of naringin are shown in Table 1.
The reaction was promoted by adding NGase-CLEAs to
2mLofsodiumacetatebuﬀer (20mM, pH = 4.0) and 2mL
of naringin solutions with concentrations equal to those
expressed in the table on the design experimental CCRD
(Table 1) .T h er e a c t i o no c c u r sf o r3 0m i n u t e sa td i ﬀerent
temperatures speciﬁed in Table 1. Aliquots of 75μL at the
end of the experiments were withdrawn, to carry out the
determination of reducing sugars by DNS method.
3. Results and Discussion
Initially, the immobilization of naringinase in cross-linked
aggregates (NGase-CLEAs) was tried using ammonium
sulphateasprecipitationagentanddiﬀerentnaringinasecon-
centrations. However, there was any formation of precipitate
andev enafter48hoursat0 ◦C,nomodiﬁcationwasobserved
in the reaction medium. Also, the addition of the cross-
linking agent, glutaraldehyde, to the diﬀerent naringinase
solutions (1mg/mL to 4mg/mL) did not result in aggregate
formation. Nevertheless, it led to the appearance of a yellow
to brown color, depending on the exposure time (2, 6, 24,
48h). This fact suggests the occurrence of a colorimetric
reaction between glutaraldehyde and ammonium sulphate
and/or proteins, without precipitation.
Therefore, others precipitant agents were tested for
NGase-CLEAs formation, namely, polyethylene glycol 6000
(PEG 6000) and tert-butyl alcohol. With the precipitant,
PEG 6000, an increase in viscosity was observed, after
agitation of the medium for 1h. The addition of the cross-
linkingagent,glutaraldehyde,ledtotheformationofenzyme
aggregates, which increased with storage for 48 hours in an
ice bath. Afterwards, these PEG-NGase-CLEAs were used in
naringin bioconversion trials. However, these PEG-NGase-
CLEAs were unstable in sodium acetate buﬀer, leading to a
suspension, even after successive centrifugations.
The precipitant agent, tert-butyl alcohol, was studied in
naringinase solutions at diﬀerent pH values (4.0, 6.0, and
10.0) (Figure 1), following the studies of Sheldon [1]a n d
Wilson et al. [4] that mentioned the need of higher pH to
form CLEAs. In addition, the inﬂuence of naringinase con-
centration and glutaraldehyde was also evaluated (Figure 1).
The addition of tert-butyl alcohol to diﬀerent environ-
ments at temperatures of 7◦Ca n d1 0 ◦C led to crystallization
of the alcohol. This problem was overcome with agitation at
60rpm for 1h, allowing the dissolution and the formation4 Enzyme Research
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Figure 1:ReducingsugarsformationwithNGase-CLEAswith[Naringin] =0.5mg/mL,pH4.0,temperatur e30 ◦C,and100rpm.TheCLEAs
wereproducedwiththeprecipitanttert-butylalcohol,atpH4.0,6.0and10.0,withdiﬀerentnaringinaseconcentrationsandthecross-linking
agent, glutaraldehyde at 2% and 3%.
of a solution with tert-butyl alcohol [50% (v/v)] and
naringinase solutions. However, these conditions did not
allow the formation of a precipitate, unlike observed by
Sheldon [1] and Wilson et al. [4] with penicillin acylase.
Therefore, only the addition of the cross-linking agent,
glutaraldehyde, under shaking led to the formation of a
suspension. This suspension, after 12h to 24h, had a lattice
aspect and 48h later consistent aggregates were formed, after
successive centrifugations.
The increase of pH, respectively, from 4.0 to 6.0 and
10.0 resulted in smaller amounts of aggregates formation.
Moreover, in order to reduce the time for CLEAs formation,Enzyme Research 5
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Figure 2: Time-course of reducing sugars formation and naring-
inase activity using NGase-CLEAs (precipitant: tert-butyl alcohol
and cross-linking agent: glutaraldehyde 3%) in acetate buﬀer
(20mM) pH 4.0, with diﬀerent naringin concentrations, at 30◦C,
100rpm.
bicarbonate buﬀer and borohydride sodium were added to
the medium containing naringinase, tert-butyl alcohol, and
g l u t a r a l d e h y d e .H o w e v e r ,a f t e r2 h ,t h e r ew a sn oC L E A s
formation. This result was the opposite to what had been
described by Cao et al. [3] on the immobilization of
penicillin acylase.
In this work, an increased formation of cross-linked
aggregates was attained with higher enzyme concentrations
(2–4mg/mL), despite the amount of glutaraldehyde added
(2 and 3%). This improvement may be attributed to the
amino acids involved in bonding between the enzyme and
glutaraldehyde. Some authors reported that the number of
lysine residues present in the enzyme [5, 6]i sa ni m p o r t a n t
factor in the formation of stables CLEAs, like the ratio of
protein/glutaraldhyde [3].
In further work, the NGase-CLEAs were obtained with
the precipitant, tert-butyl alcohol, and the cross-linking
agent, glutaraldehyde during 48h.
3.1. NGase-CLEAs Activity Studies. The naringin hydrolysis
was carried out with naringinase immobilized on CLEAs
(tert-butyl alcohol plus glutaraldehyde), at 30◦C, under
shaking of 100rpm. This hydrolysis was carried out using
NGase-CLEAs produced at various pH (4.0, 6.0, and 10.0),
with diﬀerent naringinase concentrations (0.5, 1.0, 2.0,
4.0mg/mL) for 24h (Figure 1).
A decreased in reducing sugars concentration was
observed in CLEAs produced with naringinase immobilized
at higher pH (6.0 and 10.0) (Figure 1).
At pH 4.0 using glutaraldehyde in a concentration
of 2% and 3%, and naringinase in a concentration of
0.5mg/mL and 2.0mg/mL led, respectively, to the forma-
tion of 0.34mg/mL and 0.39mg/mL of reducing sugars
(Figure 1). Noteworthy was the high initial activity of
naringinase in NGase-CLEAs, namely after 2h, a reducing
sugars concentration of 0.261mg/mL was obtained.
Further studies were performed with NGase-CLEAs, pH
4.0, tert-butyl alcohol, and glutaraldehyde (3%), namely,
time-course, substrate concentration and stability.
A linear relation for reducing sugars formation was
observed during the ﬁrst 30 minutes enzymatic reaction,
in reaction time-course (10, 20, 30, 60, and 120 minutes)
evaluation with diﬀerent naringin concentration, at 30◦C,
100rpm.
An activity of 20μg/min·mL was obtained with naring-
inase in a concentration of 0.5mg/mL (Figure 2). I.A.C.
Ribeiro and M.H.L. Ribeiro [19] described enzymatic activ-
ities of 12μg/mL·min with naringinase immobilized in k-
carrageenan, at 30◦C, and pH 4.0.
Diﬀerent naringin concentrations were hydrolyzed to
rhamnose and glucose and naringenin, allowing kinetic con-
stants evaluation (Figure 2). The kinetic proﬁle of naringin
hydrolysis using immobilized naringinase in CLEAs obeys to
the Michaelis–Menten model. The values of Km and Vmax
were, respectively, 0.36mM and 0.127mM/min. Vila Real et
al.[9]referredaKm of0.55mMandaVmax of0.063mM/min
for free naringinase at 30◦C and pH 4.0, while Pedro et al.
[20] mentioned values of 0.303mM and 0.042mM/min for
naringinase immobilized in calcium alginate.
3.2. Operational Stability of NGase-CLEAs. The production
of an immobilized form of a biocatalyst is typically per-
formed in a batch run, where large amounts result. It is
therefore a key issue, particularly if large scale application
is envisaged, to ensure that the decay of catalytic activity of
the immobilized biocatalyst is as reduced as possible. Since
such decay is nevertheless inevitable, it is considered to be of
relevance to have a sound estimate of the rate of such decay,
irrespectively of the pattern of stability decay proﬁle of the
free enzyme.
In this work, the operational stability of NGase-CLEAs
was evaluated at 30◦C, pH 4.0, 100rpm with naringin in
a concentration of 0.5mg/mL. The activity of the freshly
prepared matrices in the ﬁrst run was deﬁned as 100% (A0).
The naringinase residual activity was evaluatedand as shown
in Figure 3, above 90% until the third use. A decrease to 30%
was observed after four reutilizations.
To describe the deactivation kinetics, each experimental
run was converted to the fraction of the original activity, that
is, its residual activity. This residual activity, Ar,( A × A
−1
0 ),
was deﬁned as the ratio between the speciﬁc activity after
each run (A) and the speciﬁc activity of the ﬁrst run (A0).
The reuse of the encapsulated naringinase can be
described adequately by a serial enzyme deactivation se-
quence (1) involving a ﬁrst-order deactivation sequence and
an active intermediate.
Ar =

1+
α1k1
k2 −k1

e
−k1t −

α1k1
k2 −k1

e
−k2t,( 1 )
k1 and k2 are ﬁrst and second deactivation rate coeﬃcients,
respectively;A0,A1,andA2 arespeciﬁcactivitiesoftheinitial
active enzyme, enzyme intermediate, and ﬁnal enzyme state,
respectively;α1 andα2 arethespeciﬁcactivitiesratioA1×A
−1
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Table 2: Eﬀects and respective signiﬁcance levels (p) of [Naringin] and temperature (T) on reducing sugars formation and naringinase
residual activity (Ar).
Factor [Reducing sugars] (mg/mL) Activity (mg/mL·min)
(p)( p)
[Naringin] (linear) 0.3471 0.0094 11.578 0.0094
[Naringin] (quadratic) −0.2340 0.0666 −7.804 0.0665
Temperature (linear) 0.2381 0.0475 7.944 0.0477
Temperature (quadratic) −0.4551 0.0107 −15.175 0.0107
[Naringin]× temperature 0.1555 0.2491 5.175 0.2497
∗Naringin hydrolysis in acetate buﬀer (20mM) pH 4.0 with NGase-CLEAs (NGase 2mg/mL).
Table 3: Second-order model equations for the response surfaces ﬁtted to the experimental data points of reducing sugars formation and
naringinase residual activity (Ar) against naringin (NG) and temperature (T).
System Model equations R2 R2
adj
NGase-CLEAs [Reducing sugars] = −1.887 + 0.272 [NG] − 0.052 [NG]2 + 0.089 T− 0.001 T2 + 0.0035 [NG] ×T 0.910 0.815
[Activity] = −62.959 + 2.955 [NG] − 0.034 [NG]2 + 9.089 T− 1.734 T2 + 0.115 [NG] × T 0.910 0.815
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Figure 3: Operational stability of naringinase (NGase-CLEAs), at
30◦C, acetate buﬀer pH 4.0, 100rpm.
and A2 × A
−1
0 ,r e s p e c t i v e l y[ 21] .T h eﬁ to fS a d a n a ’ sm o d e l
(1) to experimental data was carried out using “Solver” add-
in from Excel for Windows, version 8.0 SR2, by minimising
the residual sum of squares between the experimental data
points and those estimated by the respective model and
considering the following options: Newton method; 100
iterations, precision of 10−5; 5% of tolerance and 0.001
convergence.
A biphasic deactivation nature was observed, where the
ﬁnal state was totally inactivated (α2 = 0). A k1 of 1.26h−1
and an α1 of 1.76 were obtained.
The half-life of the biocatalyst, t1/2, that is, the operation
timerequiredforhalftheenzymeactivitytobelostasaresult
of deactivation was of 4.5h.
3.3. Modelling NGase-CLEAs Activity as a Function of Sub-
strate and Temperature. Naringin hydrolysis was performed
using naringinase encapsulated on CLEAs, according to
a statistical design “central composite rotatable design”
(CCRD), depending on the concentration of naringin and
temperature. The experiments were carried out according
to a factorial design 22 and a CCRD, as a function of both
naringin concentration (NG) and temperature (T).
The experimental results showed that reducing sug-
ars formation and naringinase activity was aﬀected by
temperature and naringin concentration individually and
interactively (Figure 4).
The signiﬁcant eﬀects of naringin concentration and
temperature and interaction of (Naringin) × Temperature
on the reducing formation and naringinase activity are
shown in Table 2.
A least-squares technique was used to ﬁt quadratic poly-
nomial models and obtain multiple regression coeﬃcients
forreducingsugarsformationandnaringinaseactivitywhich
are summarized in Table 3. Examination of these coeﬃcients
indicatedthatlinearandquadratictermsofnaringinconcen-
tration and temperature, respectively, were signiﬁcant P<
0.01 for reducing sugars formation and naringinase activity
(Table 2). A positive interaction between the variables tested
(T × NG) on naringinase activity indicated that higher
activities are obtained at higher temperatures and naringin
concentration.
Therefore,curvedsurfaceswereﬁttedtotheexperimental
data (Figure 4). Partial diﬀerentiation of these polynomial
equations was used to ﬁnd the optimum points, that is,
the stationary points. The least-square estimates of the
coeﬃcients of the model were calculated from the values
of the response for each experiment in the chosen experi-
mental matrix. The relationships between independent and
dependent variables in the three-dimensional representa-
tions are convex surfaces, for reducing sugars formation
and naringinase activity (Figure 4). The obtained response
surface(Figure 4)wasdescribedbysecond-orderpolynomial
equations to the experimental data points, as a function of
temperature and naringin concentration (Table 3). In the
design of these models, the signiﬁcant eﬀects (P<0.05),Enzyme Research 7
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Figure 4: Response surface ﬁtted to the experimental data points, corresponding to naringinase residual activity, as function of naringin
concentration and temperature, with NGase-CLEAs, in acetate buﬀer (20mM) pH 4.0.
and those that presented a conﬁdent range smaller than the
value of the eﬀect or smaller than the standard deviation
were included in these model equations. In fact, these later
eﬀects have a lower probability, but their values are not small
enough to be neglected.
The high values of R2 and R2
adj of the model (Table 3)
showed a close agreement between the experimental results
and the theoretical values predicted by the model [22]. The
adjusted coeﬃcients of determination for reducing sugars
formation and naringinase activity (R2
adj = 0.815) implied
that 81.5% of the variations could be explained by the ﬁtted
model.
Enzyme activity appears to be optimal within the ranges
tested. A concentration of reducing sugars of 1.0mg/mL
and a maximum naringinase activity of 30mg/mL·min is
expected at 50◦C with 3mg/mL of naringin.
Once tested, the model may be used to predict the
value of the response(s) under any conditions within the
experimental region.
In future work, this system will be tested in addition to
naringinase immobilization, to enzyme puriﬁcation.
4. Conclusions
In this work, NGase-CLEAs were produced with a high
enzymatic activity, allowing the hydrolysis of naringin.
NGase-CLEAs with greater stability and a higher activity
of 20μg/mL·min were produced with tert-butyl alcohol as
precipitating agent, glutaraldehyde (3%) as cross-linking
agent, at pH 4, and temperature between 7◦Ca n d1 0 ◦C.
The response surface methodology (RSM) enabled the
assessment of the combined eﬀects of temperature and
naringin concentration for reducing sugars production
and naringinase activity. The modeling of hydrolysis of
naringin, with temperature and naringin concentration,
catalyzed by NGase-CLEAs was described by response sur-
faces of convex form, and a maximum naringinase activity
of 30mg/mL·min is expected at 50◦Cw i t h3 m g / m Lo f
naringin.
References
[1] R. A. Sheldon, “Cross-linked enzyme aggregates (CLEAs):
stable and recyclable biocatalysts,” Biochemical Society Trans-
actions, vol. 35, no. 6, pp. 1583–1587, 2007.
[2] K. Sangeetha and T. E. Abraham, “Preparation and characteri-
zation of cross-linked enzyme aggregates (CLEA) of Subtilisin
for controlled release applications,” International Journal of
Biological Macromolecules, vol. 43, no. 3, pp. 314–319, 2008.
[3] L. Cao, L. M. Van Langen, F. Van Rantwijk, and R. A. Sheldon,
“Cross-linked aggregates of penicillin acylase: robust catalysts
for the synthesis of β-lactam antibiotics,” Journal of Molecular
Catalysis B, vol. 11, no. 4-6, pp. 665–670, 2001.
[4] L. Wilson, A. Illanes, L. Soler, and M. J. Henr´ ıquez, “Eﬀect
of the degree of cross-linking on the properties of diﬀerent
CLEAs of penicillin acylase,” Process Biochemistry, vol. 44, no.
3, pp. 322–326, 2009.
[5] D. Brady and J. Jordaan, “Advances in enzyme immobilisa-
tion,” Biotechnology Letters, vol. 31, no. 11, pp. 1639–1650,
2009.
[6] C. Roberge, D. Amos, D. Pollard, and P. Devine, “Preparation
and application of cross-linked aggregates of chloroperoxidase
with enhanced hydrogen peroxide tolerance,” Journal of
Molecular Catalysis B, vol. 56, no. 1, pp. 41–45, 2009.
[7] A. E. Fazary, S. Ismadji, and Y. H. Ju, “Biochemical studies
on native and cross-linked aggregates of Aspergillus awamori
feruloyl esterase,” International Journal of Biological Macro-
molecules, vol. 44, no. 3, pp. 240–248, 2009.
[8] P. Gupta, K. Dutt, S. Misra, S. Raghuwanshi, and R. K.
Saxena, “Characterization of cross-linked immobilized lipase
from thermophilic mould Thermomyces lanuginosa using
glutaraldehyde,” Bioresource Technology, vol. 100, no. 18, pp.
4074–4076, 2009.
[9] H. J. Vila Real, A. J. Alfaia, A. R. T. Calado, and M. H.
L. Ribeiro, “High pressure-temperature eﬀects on enzymatic
activity: naringin bioconversion,” Food Chemistry, vol. 102,
no. 3, pp. 565–570, 2007.
[10] M. Puri and U. C. Banerjee, “Production, puriﬁcation,
and characterization of the debittering enzyme naringinase,”
Biotechnology Advances, vol. 18, no. 3, pp. 207–217, 2000.8 Enzyme Research
[ 1 1 ]V .V .Z v e r l o v ,C .H e r t e l ,K .B r o n n e n m e i e r ,A .H r o c h ,J .
Kellermann, and W. H. Schwarz, “The thermostable α-L-
rhamnosidase RamA of Clostridium stercorarium: biochem-
ical characterization and primary structure of a bacterial α-
L-rhamnoside hydrolase, a new type of inverting glycoside
hydrolase,”MolecularMicrobiology,vol.35,no.1,pp.173–179,
2000.
[12] I. A. Ribeiro, J. Rocha, B. Sepodes, H. Mota-Filipe, and
M. H. Ribeiro, “Eﬀect of naringin enzymatic hydrolysis
towards naringenin on the anti-inﬂammatory activity of both
compounds,” Journal of Molecular Catalysis B, vol. 52-53, no.
1-4, pp. 13–18, 2008.
[13] J. Marques, H. J. Vila-Real, A. J. Alfaia, and M. H. L. Ribeiro,
“Modelling of the high pressure-temperature eﬀects on
naringin hydrolysis based on response surface methodology,”
Food Chemistry, vol. 105, no. 2, pp. 504–510, 2007.
[14] M. I. Amaro, J. Rocha, H. Vila-Real et al., “Anti-inﬂammatory
activity of naringin and the biosynthesised naringenin by
naringinase immobilized in microstructured materials in
a model of DSS-induced colitis in mice,” Food Research
International, vol. 42, no. 8, pp. 1010–1017, 2009.
[15] M. H. L. Ribeiro, C. Afonso, H. J. Vila-Real, A. J. Alfaia, and
L. Ferreira, “Contribution of response surface methodology
to the modeling of naringin hydrolysis by naringinase Ca-
alginate beads under high pressure,” LWT-Food Science and
Technology, vol. 43, no. 3, pp. 482–487, 2010.
[16] Y. C. Chen, S. C. Shen, and H. Y. Lin, “Rutinoside at
C7 attenuates the apoptosis-inducing activity of ﬂavonoids,”
BiochemicalPharmacology,vol.66,no.7,pp.1139–1150,2003.
[17] G. L. Miller, “Use of dinitrosalicylic acid reagent for determi-
nation of reducing sugar,” Analytical Chemistry, vol. 31, no. 3,
pp. 426–428, 1959.
[18] M. M. Bradford, “A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein dye binding,” Analytical Biochemistry, vol.
72, no. 1-2, pp. 248–254, 1976.
[19] I. A. C. Ribeiro and M. H. L. Ribeiro, “Kinetic mod-
elling of naringin hydrolysis using a bitter sweet alfa-
rhamnopyranosidase immobilized in k-carrageenan,” Journal
of Molecular Catalysis B, vol. 51, no. 1-2, pp. 10–18, 2008.
[20] H. A. L. Pedro, A. J. Alfaia, J. Marques, H. J. Vila-Real, A.
Calado, and M. H. L. Ribeiro, “Design of an immobilized
enzyme system for naringin hydrolysis at high-pressure,”
Enzyme and Microbial Technology, vol. 40, no. 3, pp. 442–446,
2007.
[21] J. P. Henley and A. Sadana, “Categorization of enzyme
deactivations using a series-type mechanism,” Enzyme and
Microbial Technology, vol. 7, no. 2, pp. 50–60, 1985.
[22] M. Giovanni, “Response surface methodology and product
optimization,” Food Technology, vol. 37, pp. 41–45, 1983.